Greenwich Lifesciences CEO and CFO Snehal Patel acquires $20,430 of common shares
GLSI•Insider purchase details
Greenwich Lifesciences CEO and CFO Snehal Patel bought 1,500 common shares at $13.62 each.
Patel’s direct holding rose to 5,609,202 shares.
